Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Annamaria Tomasso
Observed name:
A. Tomasso
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico,
Istituto Nazionale di Riposo e Cura per Anziani
ORCID:
0009-0005-5361-7463
Observed ORCID:
0009-0005-5361-7463
OpenAlex ID:
A5108138974
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia
2020
·
Andrea Corbingi
, Idanna Innocenti
, et al.
·
British Journal of Haematology
·
28
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study
2022
·
Idanna Innocenti
, Gianluigi Reda
, et al.
·
Haematologica
·
22
PDF
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed
2024
·
Alberto Fresa
, Idanna Innocenti
, et al.
·
Cancers
·
14
PDF
Richter transformation in Chronic Lymphocytic Leukemia
2022
·
Idanna Innocenti
, Giulia Benintende
, et al.
·
Hematological Oncology
·
12
Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
2021
·
Alberto Fresa
, Francesco Autore
, et al.
·
Journal of Clinical Medicine
·
12
PDF
CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia
2021
·
Giovanni D’Arena
, Candida Vitale
, et al.
·
Cancers
·
10
PDF
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practice
2025
·
Anna Maria Frustaci
, Andrea Galitzia
, et al.
·
Haematologica
·
8
PDF
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study
2024
·
Giovanni D’Arena
, Candida Vitale
, et al.
·
Cancers
·
8
PDF
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid‐19 pandemics
2022
·
Idanna Innocenti
, Annamaria Tomasso
, et al.
·
Hematological Oncology
·
8
PDF
Purging with chlorambucil to prevent infusion‐related reaction before obinutuzumab administration: A monocentric pilot experience
2019
·
Francesco Autore
, Alberto Fresa
, et al.
·
Hematological Oncology
·
8
Non‐overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia
2021
·
Alberto Fresa
, Francesco Autore
, et al.
·
Hematological Oncology
·
6
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax
2019
·
Idanna Innocenti
, Francesca Morelli
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
6
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience
2024
·
Idanna Innocenti
, Antonio Mosca
, et al.
·
HemaSphere
·
5
PDF
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature
2024
·
Alberto Fresa
, Idanna Innocenti
, et al.
·
Therapeutic Advances in Hematology
·
4
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience
2023
·
Idanna Innocenti
, Alberto Fresa
, et al.
·
Cancers
·
4
PDF
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia
2022
·
Riccardo Moia
, Riccardo Dondolin
, et al.
·
Hematological Oncology
·
4
PDF
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study
2022
·
Alberto Fresa
, Francesco Autore
, et al.
·
Blood Advances
·
4
PDF
Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience
2025
·
Idanna Innocenti
, Annamaria Tomasso
, et al.
·
Hematological Oncology
·
3
PDF
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study
2022
·
Giulia Benintende
, Idanna Innocenti
, et al.
·
Haematologica
·
3
PDF
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study
2025
·
Alberto Fresa
, Idanna Innocenti
, et al.
·
Blood Advances
·
2
PDF
CLL-251: Venetoclax for CLL Patients Outside Clinical Trials: An Italian Real-Life Experience
2020
·
Francesca Morelli
, Annamaria Tomasso
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Treatability with ibrutinib plus venetoclax in patients with CLL in the real-world. the eric international thrive study
2025
·
Andrea Visentin
, Thomas Chatzikonstantinou
, et al.
·
Blood
·
1
PDF
Incidence of Atrial Fibrillation (AF) in Chronic Lymphocytic Leukemia (CLL) Patients: A Real-World Retrospective Comparison of Ibrutinib and Acalabrutinib
2024
·
Roberta Murru
, Idanna Innocenti
, et al.
·
Blood
·
1
PDF
Prevention of CINV in Patients with Multiple Myeloma or Lymphoma Undergoing Hematopoietic Stem Cell Transplantation: NEPA Versus Ondansetron. a Monocentric Real-Life Experience
2023
·
Idanna Innocenti
, Annamaria Tomasso
, et al.
·
Blood
·
1
PDF
Impact of Serum Immunoglobulin Subsets and Levels on Chronic Lymphocytic Leukemia Natural History: A Retrospective Multicentric Italian Experience
2019
·
Luca Laurenti
, Andrea Corbingi
, et al.
·
Blood
·
1
Show more works
View as search
Works count:
55
Citation count:
177
H-index:
8
I10-index:
6
Year
Topic
Type